Strata Skin Sciences ROA 2012-2025 | SSKN
Current and historical return on assets (ROA) values for Strata Skin Sciences (SSKN) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Strata Skin Sciences ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-09-30 | $-0.01B | $0.03B | -33.59% |
| 2025-06-30 | $-0.01B | $0.03B | -31.43% |
| 2025-03-31 | $-0.01B | $0.03B | -24.16% |
| 2024-12-31 | $-0.01B | $0.04B | -25.81% |
| 2024-09-30 | $-0.01B | $0.04B | -22.22% |
| 2024-06-30 | $-0.01B | $0.04B | -18.93% |
| 2024-03-31 | $-0.01B | $0.04B | -23.91% |
| 2023-12-31 | $-0.01B | $0.04B | -22.80% |
| 2023-09-30 | $-0.01B | $0.05B | -13.79% |
| 2023-06-30 | $-0.01B | $0.06B | -13.40% |
| 2023-03-31 | $-0.01B | $0.05B | -11.54% |
| 2022-12-31 | $-0.01B | $0.05B | -11.21% |
| 2022-09-30 | $-0.01B | $0.05B | -13.40% |
| 2022-06-30 | $-0.01B | $0.05B | -13.79% |
| 2022-03-31 | $0.00B | $0.06B | -8.25% |
| 2021-12-31 | $0.00B | $0.05B | -6.49% |
| 2021-09-30 | $0.00B | $0.05B | -4.32% |
| 2021-06-30 | $0.00B | $0.05B | -4.32% |
| 2021-03-31 | $-0.01B | $0.05B | -10.75% |
| 2020-12-31 | $0.00B | $0.05B | -8.60% |
| 2020-09-30 | $-0.01B | $0.05B | -10.75% |
| 2020-06-30 | $-0.01B | $0.05B | -10.70% |
| 2020-03-31 | $0.00B | $0.05B | -8.47% |
| 2019-12-31 | $0.00B | $0.05B | -8.38% |
| 2019-09-30 | $0.00B | $0.05B | -6.25% |
| 2019-06-30 | $0.00B | $0.05B | -6.32% |
| 2019-03-31 | $0.00B | $0.05B | -6.38% |
| 2018-12-31 | $0.00B | $0.05B | -9.04% |
| 2018-09-30 | $-0.01B | $0.05B | -19.05% |
| 2018-06-30 | $-0.02B | $0.05B | -51.85% |
| 2018-03-31 | $-0.02B | $0.04B | -52.83% |
| 2017-12-31 | $-0.02B | $0.04B | -50.91% |
| 2017-09-30 | $-0.02B | $0.04B | -42.60% |
| 2017-06-30 | $-0.01B | $0.04B | -13.95% |
| 2017-03-31 | $-0.01B | $0.04B | -11.56% |
| 2016-12-31 | $0.00B | $0.04B | -8.99% |
| 2016-09-30 | $0.00B | $0.04B | -8.65% |
| 2016-06-30 | $-0.01B | $0.04B | -28.87% |
| 2016-03-31 | $-0.02B | $0.05B | -43.14% |
| 2015-12-31 | $-0.03B | $0.05B | -65.12% |
| 2015-09-30 | $-0.03B | $0.05B | -92.96% |
| 2015-06-30 | $-0.02B | $0.05B | -80.70% |
| 2015-03-31 | $-0.01B | $0.02B | -77.78% |
| 2014-12-31 | $-0.02B | $0.02B | -82.19% |
| 2014-09-30 | $-0.01B | $0.02B | -83.58% |
| 2014-06-30 | $-0.02B | $0.01B | -135.71% |
| 2014-03-31 | $-0.03B | $0.02B | -152.11% |
| 2013-12-31 | $-0.03B | $0.01B | -120.93% |
| 2013-09-30 | $-0.03B | $0.01B | -121.35% |
| 2013-06-30 | $-0.03B | $0.03B | -104.17% |
| 2013-03-31 | $-0.02B | $0.03B | -101.10% |
| 2012-12-31 | $-0.02B | $0.02B | -103.53% |
| 2012-09-30 | $-0.02B | $0.02B | -84.85% |
| 2012-06-30 | $-0.02B | $0.02B | -88.89% |
| 2012-03-31 | $-0.02B | $0.03B | -87.13% |
| 2011-12-31 | $-0.02B | $0.03B | -80.77% |
| 2011-09-30 | $-0.02B | $0.02B | -78.50% |
| 2011-06-30 | $-0.02B | $0.02B | -63.49% |
| 2011-03-31 | $-0.02B | $0.03B | -61.54% |
| 2010-12-31 | $-0.02B | $0.03B | -59.70% |
| 2010-09-30 | $-0.02B | $0.04B | -63.64% |
| 2010-06-30 | $-0.02B | $0.03B | -70.59% |
| 2010-03-31 | $-0.02B | $0.03B | -80.00% |
| 2009-12-31 | $-0.02B | $0.03B | -95.00% |
| 2009-09-30 | $-0.02B | $0.03B | -104.62% |
| 2009-06-30 | $-0.02B | $0.01B | -106.67% |
| 2009-03-31 | $-0.02B | $0.01B | -104.62% |
| 2008-12-31 | $-0.02B | $0.02B | -97.14% |
| 2008-09-30 | $-0.02B | $0.02B | -85.33% |
| 2008-06-30 | $-0.02B | $0.01B | -75.95% |
| 2008-03-31 | $-0.01B | $0.02B | -63.41% |
| 2007-12-31 | $-0.01B | $0.02B | -57.14% |
| 2007-09-30 | $-0.01B | $0.03B | -52.38% |
| 2007-06-30 | $-0.01B | $0.02B | -56.34% |
| 2007-03-31 | $-0.01B | $0.02B | -58.82% |
| 2006-12-31 | $-0.01B | $0.02B | -61.54% |
| 2006-09-30 | $-0.01B | $0.01B | -70.97% |
| 2006-06-30 | $-0.01B | $0.01B | -81.48% |
| 2006-03-31 | $-0.01B | $0.02B | -100.00% |
| 2005-12-31 | $-0.01B | $0.02B | -156.52% |
| 2005-09-30 | $-0.01B | $0.00B | -700.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.007B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $29.102B | 33.66 |
| Tempus AI (TEM) | United States | $9.538B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $4.901B | 0.00 |
| Doximity (DOCS) | United States | $4.888B | 20.77 |
| Hims & Hers Health (HIMS) | United States | $3.799B | 30.91 |
| Hinge Health (HNGE) | United States | $3.051B | 0.00 |
| Privia Health (PRVA) | United States | $2.657B | 166.15 |
| 10x Genomics (TXG) | United States | $2.423B | 0.00 |
| Heartflow (HTFL) | United States | $2.295B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $1.982B | 26.44 |
| Omnicell (OMCL) | United States | $1.697B | 47.28 |
| Azenta (AZTA) | United States | $1.403B | 56.39 |
| Enovis (ENOV) | United States | $1.304B | 6.85 |
| Clover Health Investments (CLOV) | United States | $1.059B | 0.00 |
| Schrodinger (SDGR) | United States | $0.883B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.829B | 0.00 |
| Phreesia (PHR) | United States | $0.754B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.711B | 0.00 |
| Talkspace (TALK) | United States | $0.654B | 131.67 |
| Standard BioTools (LAB) | United States | $0.458B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.348B | 0.00 |
| Claritev (CTEV) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.323B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.315B | 0.00 |
| Carlsmed (CARL) | United States | $0.304B | 0.00 |
| Evolent Health (EVH) | United States | $0.298B | 0.00 |
| TruBridge (TBRG) | United States | $0.280B | 12.85 |
| CapsoVision (CV) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.211B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.168B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.164B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.159B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.141B | 0.00 |
| CareCloud (CCLD) | United States | $0.095B | 5.21 |
| Outset Medical (OM) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.071B | 0.00 |
| 111 (YI) | China | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Pulmonx (LUNG) | United States | $0.060B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.038B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.033B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.019B | 0.00 |
| Movano (MOVE) | United States | $0.015B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.015B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.007B | 0.00 |
| Zhongchao (ZCMD) | China | $0.006B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.005B | 0.00 |
| PROFUSA (PFSA) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |